Department of Infectious Diseases, St James's Hospital, Dublin, D08 NHY1, Ireland.
Health Protection Surveillance Centre, Dublin, D01 A4A3, Ireland.
QJM. 2024 Sep 1;117(9):638-646. doi: 10.1093/qjmed/hcae093.
Healthcare workers (HCWs) are at increased risk of SARS-CoV-2 infection. This risk persists despite the implementation of mitigating factors, including vaccination. The ongoing impact of incident SARS-CoV-2 infection and symptomatic COVID-19 disease in vaccinated HCWs is poorly understood.
We aimed to describe the epidemiology of incident SARS-CoV-2 infections, as well as investigating the serological, clinical and demographic factors associated with developing infection.
This was a multi-centre prospective longitudinal study followed a HCW cohort over a nine-month period.
Spike and nucleocapsid SARS-CoV-2 antibodies were measured at enrolment. Vaccination status, demographics and medical history were collated. Incident infection over the study period was recorded. Multivariable regression models investigated factors associated with nucleocapsid antibody status, incident infection and symptomatic infection.
About 1260 participants took part, of whom n = 1006 were anti-nucleocapsid antibody positive. Negative anti-nucleocapsid antibody was associated with older age and having a known SARS-CoV-2 acquisition risk. There were n = 274 (22%) incident infections, with n = 225 (87%) diagnosed using antigen tests. Incident infections were associated with lower anti-nucleocapsid titres, increased time since previous SARS-CoV-2 infection, and having a known acquisition risk, but were not associated with vaccination status.
This study demonstrates a high rate of incident SARS-CoV-2 infection amongst HCWs, despite broad vaccine coverage. There is a shift in diagnostics, from PCR to antigen testing. We identify at-risk groups for incident infection, and these should continue be targeted as part of risk reduction campaigns. Vaccination status and prior infection status alone are not surrogates for protection.
医护人员(HCWs)感染 SARS-CoV-2 的风险增加。尽管采取了减轻因素,包括接种疫苗,但这种风险仍然存在。接种疫苗的 HCWs 中 SARS-CoV-2 感染的持续影响和有症状的 COVID-19 疾病仍知之甚少。
我们旨在描述 SARS-CoV-2 感染的流行病学,并研究与感染发生相关的血清学、临床和人口统计学因素。
这是一项多中心前瞻性纵向研究,在九个月的时间内对 HCW 队列进行了随访。
在入组时测量了 Spike 和核衣壳 SARS-CoV-2 抗体。收集了疫苗接种状况、人口统计学和病史。记录了研究期间的感染事件。多变量回归模型调查了与核衣壳抗体状态、感染事件和有症状感染相关的因素。
约有 1260 名参与者参加了研究,其中 n=1006 人抗核衣壳抗体阳性。阴性抗核衣壳抗体与年龄较大和已知的 SARS-CoV-2 获得风险有关。共有 n=274(22%)发生了感染事件,其中 n=225(87%)通过抗原检测诊断。感染事件与较低的核衣壳抗体滴度、上次 SARS-CoV-2 感染后时间增加以及已知的获得风险有关,但与疫苗接种状况无关。
尽管广泛接种疫苗,但本研究表明 HCWs 中 SARS-CoV-2 感染的发生率很高。诊断方法从 PCR 转向抗原检测。我们确定了感染的高危人群,这些人群应继续作为减少风险活动的目标。疫苗接种状况和既往感染状况本身并不能替代保护。